https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-19 / Radiother Oncol 2015 Nov;117(2):217-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-19 / Radiother Oncol 2015 Nov;117(2):217-222015-05-19 00:00:002015-05-19 00:00:00Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-23 / Swiss Med Wkly 2015;145:w14133
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-23 / Swiss Med Wkly 2015;145:w141332015-04-23 00:00:002015-04-23 00:00:00Hyperthermia and reirradiation for locoregional recurrences in preirradiated breast cancers: a single institutional experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-18 / Breast 2015 Aug;24(4):418-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-18 / Breast 2015 Aug;24(4):418-252015-04-18 00:00:002015-04-18 00:00:00Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-01 / Breast Care (Basel) 2015 Apr;10(2):109-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-01 / Breast Care (Basel) 2015 Apr;10(2):109-162015-04-01 00:00:002015-04-01 00:00:00Hyperthermia Is Now Included in the NCCN Clinical Practice Guidelines for Breast Cancer Recurrences: An Analysis of Existing Data
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-03-02 / Biomed Res Int 2015;2015:127828
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-03-02 / Biomed Res Int 2015;2015:1278282015-03-02 00:00:002015-03-02 00:00:00Inhibitory and apoptosis-inducing effects of Newcastle disease virus strain AF2240 on mammary carcinoma cell line
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-08-01 / Int J Hyperthermia 2014 Aug;30(5):285-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-08-01 / Int J Hyperthermia 2014 Aug;30(5):285-942014-08-01 00:00:002014-08-01 00:00:00Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-05-01 / Cytotherapy 2014 Jul;16(7):934-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-05-01 / Cytotherapy 2014 Jul;16(7):934-452014-05-01 00:00:002014-05-01 00:00:00Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-01 / Immunotherapy 2014;6(3):349-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-01 / Immunotherapy 2014;6(3):349-602014-01-01 00:00:002019-02-15 08:50:00Dendritic cell-based vaccines: clinical applications in breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-11-01 / Gan To Kagaku Ryoho 2013 Nov;40(12):1596-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-11-01 / Gan To Kagaku Ryoho 2013 Nov;40(12):1596-92013-11-01 00:00:002013-11-01 00:00:00[The effect of immunotherapy and hyperthermia on patients with advanced or recurrent breast cancer]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-11-01 / Cancer J 2013 Nov-Dec;19(6):511-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-11-01 / Cancer J 2013 Nov-Dec;19(6):511-62013-11-01 00:00:002013-11-01 00:00:00Dendritic cells, inflammation, and breast cancer
